Adial Pharmaceuticals Files 8-K: Material Agreement & Equity Sales
Ticker: ADIL · Form: 8-K · Filed: May 7, 2025 · CIK: 1513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
TL;DR
Adial Pharma inked a deal and sold some stock, filing the news May 7th.
AI Summary
On May 2, 2025, Adial Pharmaceuticals, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events, including financial statements and exhibits. The filing was made on May 7, 2025.
Why It Matters
This 8-K filing indicates significant corporate activity for Adial Pharmaceuticals, including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing details a material definitive agreement and unregistered equity sales, which can introduce financial and operational risks.
Key Players & Entities
- Adial Pharmaceuticals, Inc. (company) — Registrant
- May 2, 2025 (date) — Date of earliest event reported
- May 7, 2025 (date) — Filing date
FAQ
What is the nature of the material definitive agreement entered into by Adial Pharmaceuticals?
The filing does not specify the details of the material definitive agreement, only that one was entered into on May 2, 2025.
What type of equity securities were sold by Adial Pharmaceuticals?
The filing mentions unregistered sales of equity securities but does not provide specific details on the type or amount of securities sold.
What are the key financial statements and exhibits included in this filing?
The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
When was Adial Pharmaceuticals, Inc. incorporated and in which jurisdiction?
Adial Pharmaceuticals, Inc. was incorporated in Delaware.
What is the IRS Employer Identification Number for Adial Pharmaceuticals, Inc.?
The IRS Employer Identification Number for Adial Pharmaceuticals, Inc. is 82-3074668.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).